Department of Surgery, University of Colorado School of Medicine, Aurora, CO.
Division of GI, Trauma, and Endocrine Surgery, Department of Surgery, University of Colorado School of Medicine, Aurora, CO.
J Am Coll Surg. 2019 Feb;228(2):141-147. doi: 10.1016/j.jamcollsurg.2018.11.005. Epub 2018 Nov 24.
Early blood product resuscitation reduces trauma patient mortality from hemorrhage. This mortality benefit depends on a system that can rapidly identify actively bleeding patients, initiate massive transfusion protocol (MTP), and mobilize resources to the bedside. We hypothesized that process improvement efforts that identify patients early and mobilize appropriate blood products to the bedside for immediate use would improve mortality.
Pre-implementation, MTP activation was at the discretion of the trauma surgeon, and only PRBCs were immediately available. In June 2016, the Assessment of Blood Consumption (ABC) score was incorporated in our pre-hospital triage process, and a process for thawed plasma to be available was developed. We performed a retrospective review of patients who were hypotensive on arrival or had MTP activated. We compared mortality and MTP component ratios 15 months pre- vs 15 months post-implementation.
Activations of MTP increased 6-fold, while the specificity of the process remained the same. In patients receiving MTP, appropriate blood product transfusion ratios increased 44%. Overall and penetrating trauma mortality improved by 23% and 41%, respectively. When divided by the Injury Severity Score (ISS), penetrating trauma mortality decreased by 65% for the ISS subgroup 15 to 24 and by 38% for ISS subgroup ≥ 25. Length of stay, ICU length of stay, and readmission rates were not significantly different.
Delivery of balanced blood product resuscitation is essential to confer mortality benefits. Process improvement directed at early recognition of the hemorrhagic patient, immediate product availability, and product delivery to the bedside for transfusion allows for mortality reduction without increased resource use.
早期的血液制品复苏可降低创伤患者因出血导致的死亡率。这种死亡率的降低依赖于一个能够快速识别有活动性出血的患者、启动大量输血方案(MTP)并调动资源到床边的系统。我们假设,通过早期识别患者并将适当的血液制品迅速运送到床边以供立即使用的流程改进措施,将提高死亡率。
在实施之前,MTP 的激活取决于创伤外科医生的判断,并且只有 PRBCs 可以立即获得。在 2016 年 6 月,评估血液消耗(ABC)评分被纳入我们的院前分诊流程中,并制定了解冻血浆随时可用的流程。我们对到达时低血压或已激活 MTP 的患者进行了回顾性审查。我们比较了实施前 15 个月和实施后 15 个月的死亡率和 MTP 成分比例。
MTP 的激活增加了 6 倍,而该流程的特异性保持不变。在接受 MTP 的患者中,适当的血液制品输血比例增加了 44%。总体和穿透性创伤的死亡率分别提高了 23%和 41%。当按损伤严重程度评分(ISS)进行划分时,ISS 评分 15-24 的穿透性创伤死亡率降低了 65%,ISS 评分≥25 的死亡率降低了 38%。住院时间、ICU 住院时间和再入院率没有显著差异。
提供平衡的血液制品复苏对于获得死亡率降低至关重要。针对早期识别出血患者、立即获得产品以及将产品输送到床边进行输血的流程改进措施,可在不增加资源使用的情况下降低死亡率。